CompletedPhase 2NCT01056705

The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains (IPV)

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chinese Academy of Medical Sciences
Principal Investigator
Liao Guoyang, PHD
Institute of Medical Biology, Chinese Academy of Medical Sciences
Intervention
Inactivated Poliomyelitis Vaccine (Sabin strains)(biological)
Enrollment
500 target
Eligibility
All sexes
Timeline
20092010

Study locations (1)

Collaborators

Guangxi Center for Disease Control and Prevention · National Institute for the Control of Pharmaceutical and Biological Products, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01056705 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis

← Back to all trials